Integrating the technologies revolutionising immunotherapy and its impact on vaccines development
After an incredibly successful two years in San Diego, the World Vaccine and Immunotherapy Congress is moving to San Fransisco in 2019 to bring you even more content, learning and business development opportunities so you can take advantage of the rich biotech and funding environment that the West Coast offers.
Whilst still focussing on the vaccine and immunotherapy industry the scope of the event has expanded considerably and will delve deeper into topics surrounding vaccine development, cancer immunotherapy, funding and partnerships as well as exploring new topics in clinical trials & development, bioprocessing, manufacture and delivery, and the development and use of antibodies for both infectious diseases and cancer.
This is the congress for top decision makers of the vaccine and immunotherapy industry with both scientific and commercial interests, specifically interested in both learning and/or partnering.
What to expect?
Providing attendees one stop progressive scientific and strategic solutions to the vaccine and immunotherapy industry, through executive level commentary, case studies and real-time analysis from key stakeholders to bring about faster, more cost-effective and more efficacious vaccines.